DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

Abroad (travel likely)RecruitingPHASE2

Conditions

Breast Cancer · Breast Cancer Female · Metastatic Triple-Negative Breast Carcinoma · ER Positive Breast Cancer · HER2-negative Breast Cancer · HER2 Negative Breast Carcinoma · ER-negative Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Sarah Sammons, MD

    Principal Investigator

    Dana-Farber Cancer Institute